Log in
Enquire now
‌

US Patent 7235641 Bispecific antibodies

Patent 7235641 was granted and assigned to Micromet on June, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Micromet
Micromet
0
Date Filed
December 22, 2003
0
Date of Patent
June 26, 2007
0
Patent Application Number
10743697
0
Patent Citations Received
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11884732 Proteins binding HER2, NKG2D and CD16
0
‌
US Patent 11939384 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11952421 Bispecific antibodies against CD3EPSILON and ROR1
0
‌
US Patent 12006366 Methods and compositions for preventing type 1 diabetes
0
‌
US Patent 12016885 Method of solubilizing TDP-43 protein aggregates in amyotrophic lateral sclerosis using a microvascular endothelial cell expressing an anti-TDP-43 Fab
0
‌
US Patent 12016886 Microvascular endothelial cell comprising a nucleic acid encoding an anti-TDP-43 fab
0
‌
US Patent 12110611 Conditionally active biological proteins
0
‌
US Patent 11685781 Variant CD3-binding domains and their use in combination therapies for the treatment of disease
0
‌
US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer
0
•••
Patent Inventor Names
Patrick Baeuerle
0
Peter Kufer
0
Meera Berry
0
Christian Itin
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7235641
0
Patent Primary Examiner
‌
Christina Chan
0

Find more entities like US Patent 7235641 Bispecific antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.